12.9(top 1%)
Impact Factor
13.7(top 1%)
extended IF
338(top 1%)
H-Index
15.2K
authors
19.4K
papers
1.3M
citations
9.8K
citing journals
245.8K
citing authors

Most Cited Articles of Clinical Cancer Research

TitleYearCitations
Triple-negative breast cancer: clinical features and patterns of recurrence20073K
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria20092.4K
Therapeutic nanoparticles for drug delivery in cancer20082.2K
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma20042.2K
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization20042K
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases20041.9K
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer20081.7K
Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy20141.7K
Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers20131.7K
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes20071.5K
Clinical features of metastatic bone disease and risk of skeletal morbidity20061.5K
The interleukin-8 pathway in cancer20081.5K
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy20111.4K
Breast cancer molecular subtypes respond differently to preoperative chemotherapy20051.4K
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship20031.4K
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system20071K
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome20081K
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody20091K
Phase II trial of curcumin in patients with advanced pancreatic cancer2008997
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research2009960
CXCL12 (SDF-1)/CXCR4 pathway in cancer2010953
Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance2004933
Prostate-specific membrane antigen expression in normal and malignant human tissues1997927
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype2008917
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma2007896